Intellia Therapeutics, Inc.
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
Dec-21 |
Dec-20 |
Dec-19 |
Dec-18 |
Dec-17 |
Dec-16 |
Dec-15 |
Dec-14 |
| Total revenue |
0.07 |
0.06 |
0.04 |
0.05 |
0.03 |
0.06 |
0.04 |
0.03 |
0.03 |
0.02 |
0.01 |
0.00 |
| Cost of revenue |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.15 |
0.11 |
0.09 |
0.07 |
0.03 |
0.01 |
0.00 |
| Gross profit |
0.05 |
0.05 |
0.03 |
0.04 |
0.03 |
0.06 |
-0.07 |
0.03 |
0.03 |
0.02 |
-0.01 |
0.00 |
| Selling, general and administrative |
0.12 |
0.13 |
0.12 |
0.09 |
0.07 |
0.04 |
0.04 |
0.03 |
0.03 |
0.02 |
0.01 |
0.00 |
| Research and development |
0.39 |
0.47 |
0.44 |
0.42 |
0.23 |
0.15 |
0.11 |
0.09 |
0.07 |
0.03 |
0.01 |
0.01 |
| Other operating expenses |
-0.02 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
0.00 |
-0.11 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating income |
-0.44 |
-0.53 |
-0.52 |
-0.46 |
-0.27 |
-0.14 |
-0.11 |
-0.09 |
-0.07 |
-0.03 |
-0.01 |
-0.01 |
| Non-operating income (net) |
0.03 |
0.02 |
0.03 |
-0.02 |
0.00 |
0.00 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
-0.01 |
| Income before tax |
-0.41 |
-0.52 |
-0.48 |
-0.47 |
-0.27 |
-0.13 |
-0.10 |
-0.09 |
-0.07 |
-0.03 |
-0.01 |
-0.01 |
| Income tax expense |
|
|
-0.05 |
0.02 |
-0.01 |
-0.01 |
-0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net income |
-0.41 |
-0.52 |
-0.48 |
-0.47 |
-0.26 |
-0.13 |
-0.10 |
-0.09 |
-0.07 |
-0.03 |
-0.01 |
-0.01 |
Show Quarterly Income Statement
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Dec-23 |
Sep-23 |
Jun-23 |
Mar-23 |
Dec-22 |
Sep-22 |
Jun-22 |
Mar-22 |
Dec-21 |
Sep-21 |
Jun-21 |
Mar-21 |
Dec-20 |
Sep-20 |
Jun-20 |
Mar-20 |
Dec-19 |
Sep-19 |
Jun-19 |
Mar-19 |
Dec-18 |
Sep-18 |
Jun-18 |
Mar-18 |
Dec-17 |
Sep-17 |
Jun-17 |
Mar-17 |
Dec-16 |
Sep-16 |
Jun-16 |
Mar-16 |
Dec-15 |
Sep-15 |
Jun-15 |
Mar-15 |
Dec-14 |
Jun-14 |
| Total revenue |
0.02 |
0.02 |
0.01 |
0.01 |
0.02 |
0.01 |
0.01 |
0.01 |
0.03 |
0.00 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cost of revenue |
0.00 |
0.01 |
0.08 |
|
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.12 |
0.10 |
0.10 |
0.10 |
0.09 |
0.13 |
0.07 |
0.06 |
0.06 |
0.04 |
0.04 |
0.04 |
0.04 |
0.03 |
0.03 |
0.03 |
0.03 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Gross profit |
0.01 |
0.02 |
-0.07 |
0.01 |
0.02 |
0.01 |
0.01 |
0.00 |
0.03 |
0.00 |
0.01 |
-0.10 |
-0.08 |
-0.09 |
-0.08 |
-0.08 |
-0.12 |
-0.06 |
-0.05 |
-0.05 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
-0.01 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Selling, general and administrative |
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Research and development |
0.08 |
0.09 |
0.09 |
0.10 |
0.11 |
0.12 |
0.12 |
0.11 |
0.11 |
0.11 |
0.11 |
0.12 |
0.10 |
0.10 |
0.10 |
0.09 |
0.13 |
0.07 |
0.06 |
0.06 |
0.04 |
0.04 |
0.04 |
0.04 |
0.03 |
0.03 |
0.03 |
0.03 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Other operating expenses |
0.00 |
-0.01 |
-0.08 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.12 |
-0.10 |
-0.10 |
-0.10 |
-0.09 |
-0.13 |
-0.07 |
-0.06 |
-0.06 |
-0.04 |
-0.04 |
-0.04 |
-0.04 |
-0.03 |
-0.03 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating income |
-0.10 |
-0.10 |
-0.11 |
-0.11 |
-0.12 |
-0.14 |
-0.14 |
-0.14 |
-0.11 |
-0.14 |
-0.13 |
-0.13 |
-0.11 |
-0.11 |
-0.11 |
-0.10 |
-0.14 |
-0.08 |
-0.07 |
-0.07 |
-0.05 |
-0.04 |
-0.03 |
-0.03 |
-0.03 |
-0.03 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Non-operating income (net) |
0.00 |
0.00 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
-0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Income before tax |
-0.10 |
-0.10 |
-0.10 |
-0.10 |
-0.11 |
-0.13 |
-0.14 |
-0.15 |
-0.11 |
-0.13 |
-0.12 |
-0.12 |
-0.10 |
-0.11 |
-0.11 |
-0.10 |
-0.15 |
-0.08 |
-0.07 |
-0.07 |
-0.05 |
-0.04 |
-0.03 |
-0.03 |
-0.03 |
-0.03 |
-0.02 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
-0.01 |
0.00 |
| Income tax expense |
|
|
|
|
|
|
|
|
0.00 |
0.04 |
-0.02 |
-0.01 |
-0.01 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
|
|
|
0.00 |
|
|
|
|
|
|
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Net income |
-0.10 |
-0.10 |
-0.10 |
-0.10 |
-0.11 |
-0.13 |
-0.14 |
-0.15 |
-0.11 |
-0.13 |
-0.12 |
-0.12 |
-0.10 |
-0.11 |
-0.11 |
-0.10 |
-0.15 |
-0.08 |
-0.07 |
-0.07 |
-0.05 |
-0.04 |
-0.03 |
-0.03 |
-0.03 |
-0.03 |
-0.02 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
-0.01 |
0.00 |
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
Dec-21 |
Dec-20 |
Dec-19 |
Dec-18 |
Dec-17 |
Dec-16 |
Dec-15 |
Dec-14 |
| Cash and cash equivalents |
0.16 |
0.19 |
0.23 |
0.52 |
0.12 |
0.16 |
0.06 |
0.06 |
0.34 |
0.27 |
0.08 |
0.01 |
| Short-term investments |
0.29 |
0.41 |
0.69 |
0.67 |
0.63 |
0.44 |
0.22 |
0.26 |
0.00 |
0.00 |
|
|
| Accounts receivable, net |
0.01 |
0.01 |
0.04 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.01 |
0.01 |
0.00 |
|
| Inventories |
|
|
|
-0.07 |
-0.34 |
-0.02 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
| Other current assets |
0.07 |
0.03 |
0.05 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
| Total current assets |
0.53 |
0.64 |
1.00 |
1.22 |
0.77 |
0.62 |
0.29 |
0.32 |
0.35 |
0.28 |
0.08 |
0.01 |
| Property, plant and equipment, net |
|
|
|
0.03 |
0.02 |
0.02 |
0.04 |
0.02 |
0.02 |
0.01 |
0.00 |
0.00 |
| Goodwill |
|
|
|
|
|
|
|
|
0.00 |
0.00 |
|
|
| Intangible assets |
|
|
|
|
|
|
|
|
0.00 |
0.00 |
|
|
| Long-term investments |
0.19 |
0.30 |
0.15 |
0.14 |
0.43 |
0.00 |
0.00 |
|
|
|
|
|
| Other non-current assets |
|
|
|
|
|
|
|
|
|
|
|
|
| Total assets |
0.84 |
1.19 |
1.30 |
1.52 |
1.29 |
0.68 |
0.33 |
0.35 |
0.38 |
0.30 |
0.08 |
0.01 |
|
| Accounts payable |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Short-term debt |
0.03 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
|
|
|
|
|
| Current portion of long-term debt |
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred revenue |
|
|
|
|
|
|
|
|
|
|
|
|
| Other current liabilities |
0.05 |
0.06 |
0.07 |
0.06 |
0.04 |
0.03 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
| Long-term debt |
|
|
|
|
|
|
|
|
0.00 |
0.00 |
|
|
| Capital lease obligations |
0.09 |
0.21 |
0.12 |
0.13 |
0.07 |
0.04 |
0.02 |
|
|
|
|
|
| Other non-current liabilities |
|
|
|
0.02 |
|
|
|
0.00 |
0.00 |
0.00 |
|
|
| Total liabilities |
0.17 |
0.32 |
0.25 |
0.28 |
0.25 |
0.15 |
0.06 |
0.07 |
0.08 |
0.09 |
0.01 |
0.00 |
|
| Common stock and paid-in capital |
3.26 |
3.05 |
2.71 |
2.41 |
1.74 |
0.96 |
0.57 |
0.48 |
0.42 |
0.26 |
0.09 |
0.02 |
| Retained earnings |
-2.59 |
-2.18 |
-1.66 |
-1.18 |
-0.70 |
-0.44 |
-0.30 |
-0.20 |
-0.12 |
-0.05 |
-0.02 |
-0.01 |
| Common shares outstanding |
108 |
99 |
89 |
77 |
71 |
56 |
47 |
43 |
36 |
35 |
18 |
10 |
Show Quarterly Balance Sheet
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Dec-23 |
Sep-23 |
Jun-23 |
Mar-23 |
Dec-22 |
Sep-22 |
Jun-22 |
Mar-22 |
Dec-21 |
Sep-21 |
Jun-21 |
Mar-21 |
Dec-20 |
Sep-20 |
Jun-20 |
Mar-20 |
Dec-19 |
Sep-19 |
Jun-19 |
Mar-19 |
Dec-18 |
Sep-18 |
Jun-18 |
Mar-18 |
Dec-17 |
Sep-17 |
Jun-17 |
Mar-17 |
Dec-16 |
Sep-16 |
Jun-16 |
Mar-16 |
Dec-15 |
Sep-15 |
Jun-15 |
Mar-15 |
Dec-14 |
Jun-14 |
| Cash and cash equivalents |
0.13 |
0.16 |
0.19 |
0.16 |
0.13 |
0.19 |
0.12 |
0.13 |
0.17 |
0.23 |
0.17 |
0.17 |
0.29 |
0.52 |
0.14 |
0.15 |
0.13 |
0.12 |
0.33 |
0.13 |
0.14 |
0.16 |
0.18 |
0.36 |
0.08 |
0.06 |
0.04 |
0.05 |
0.05 |
0.06 |
0.29 |
0.31 |
0.33 |
0.34 |
0.22 |
0.24 |
0.26 |
0.27 |
0.29 |
0.30 |
0.06 |
0.08 |
0.08 |
0.02 |
-0.01 |
0.01 |
|
| Short-term investments |
0.24 |
0.29 |
0.32 |
0.30 |
0.38 |
0.41 |
0.54 |
0.56 |
0.62 |
0.69 |
0.69 |
0.74 |
0.64 |
0.67 |
0.69 |
0.73 |
0.72 |
0.63 |
0.46 |
0.40 |
0.44 |
0.44 |
0.23 |
0.08 |
0.17 |
0.22 |
0.25 |
0.22 |
0.25 |
0.26 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
0.02 |
|
|
| Accounts receivable, net |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.04 |
0.04 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
| Inventories |
|
|
|
|
|
|
|
|
0.00 |
|
-0.14 |
-0.16 |
-0.23 |
-0.07 |
0.00 |
-0.03 |
0.00 |
-0.34 |
|
0.00 |
0.00 |
-0.02 |
0.00 |
|
|
0.00 |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
0.00 |
|
|
|
| Other current assets |
0.08 |
0.07 |
0.06 |
0.02 |
0.04 |
0.03 |
0.04 |
0.05 |
0.06 |
0.05 |
0.03 |
0.03 |
0.03 |
0.02 |
0.03 |
0.02 |
0.02 |
0.02 |
0.01 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.03 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.00 |
|
| Total current assets |
0.47 |
0.53 |
0.58 |
0.50 |
0.55 |
0.64 |
0.71 |
0.76 |
0.88 |
1.00 |
0.89 |
0.94 |
0.96 |
1.22 |
0.86 |
0.90 |
0.88 |
0.77 |
0.81 |
0.55 |
0.60 |
0.62 |
0.42 |
0.45 |
0.27 |
0.29 |
0.30 |
0.31 |
0.30 |
0.32 |
0.30 |
0.32 |
0.34 |
0.35 |
0.23 |
0.25 |
0.26 |
0.28 |
0.29 |
0.30 |
0.07 |
0.08 |
0.08 |
0.02 |
0.01 |
0.01 |
|
| Property, plant and equipment, net |
|
|
|
|
|
|
|
|
|
|
|
0.16 |
0.03 |
0.03 |
0.03 |
0.03 |
0.02 |
0.02 |
0.02 |
0.10 |
0.02 |
0.02 |
0.02 |
0.04 |
0.04 |
0.04 |
0.04 |
0.04 |
0.04 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
|
|
|
0.00 |
|
| Goodwill |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
| Long-term investments |
0.16 |
0.19 |
0.19 |
0.20 |
0.23 |
0.30 |
0.32 |
0.30 |
0.23 |
0.15 |
0.20 |
0.23 |
0.29 |
0.14 |
0.10 |
0.12 |
0.23 |
0.43 |
0.41 |
0.02 |
0.02 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other non-current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total assets |
0.76 |
0.84 |
0.93 |
0.90 |
0.99 |
1.19 |
1.17 |
1.19 |
1.26 |
1.30 |
1.24 |
1.32 |
1.42 |
1.52 |
1.08 |
1.11 |
1.20 |
1.29 |
1.33 |
0.67 |
0.72 |
0.68 |
0.46 |
0.49 |
0.31 |
0.33 |
0.35 |
0.35 |
0.34 |
0.35 |
0.32 |
0.34 |
0.36 |
0.38 |
0.25 |
0.26 |
0.28 |
0.30 |
0.30 |
0.31 |
0.08 |
0.08 |
0.09 |
0.02 |
|
0.01 |
|
|
| Accounts payable |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.02 |
0.01 |
0.01 |
0.00 |
0.01 |
0.01 |
0.01 |
0.00 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.00 |
|
| Short-term debt |
0.02 |
0.03 |
0.03 |
0.03 |
0.04 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Current portion of long-term debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other current liabilities |
0.04 |
0.05 |
0.05 |
0.04 |
0.04 |
0.06 |
0.05 |
0.05 |
0.04 |
0.07 |
0.06 |
0.05 |
0.04 |
0.06 |
0.06 |
0.04 |
0.04 |
0.04 |
0.02 |
0.04 |
0.02 |
0.03 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.01 |
0.01 |
0.01 |
|
0.00 |
|
| Long-term debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.02 |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
| Capital lease obligations |
0.08 |
0.09 |
0.10 |
0.10 |
0.12 |
0.21 |
0.10 |
0.11 |
0.11 |
0.12 |
0.12 |
0.12 |
0.13 |
0.13 |
0.10 |
0.07 |
0.07 |
0.07 |
0.08 |
0.07 |
0.07 |
0.04 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other non-current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.02 |
0.02 |
0.01 |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
0.02 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
| Total liabilities |
0.14 |
0.17 |
0.18 |
0.18 |
0.21 |
0.32 |
0.21 |
0.22 |
0.22 |
0.25 |
0.21 |
0.22 |
0.23 |
0.28 |
0.26 |
0.23 |
0.25 |
0.25 |
0.23 |
0.18 |
0.17 |
0.15 |
0.13 |
0.14 |
0.07 |
0.06 |
0.07 |
0.08 |
0.08 |
0.07 |
0.06 |
0.06 |
0.06 |
0.08 |
0.07 |
0.08 |
0.08 |
0.09 |
0.08 |
0.09 |
0.10 |
0.01 |
0.01 |
0.01 |
|
0.00 |
|
|
| Common stock and paid-in capital |
3.31 |
3.26 |
3.24 |
3.11 |
3.07 |
3.05 |
3.01 |
2.88 |
2.80 |
2.71 |
2.56 |
2.51 |
2.47 |
2.41 |
1.89 |
1.83 |
1.80 |
1.74 |
1.73 |
1.04 |
1.03 |
0.96 |
0.72 |
0.72 |
0.58 |
0.57 |
0.55 |
0.53 |
0.49 |
0.48 |
0.45 |
0.44 |
0.43 |
0.42 |
0.27 |
0.27 |
0.27 |
0.26 |
0.26 |
0.26 |
0.00 |
0.09 |
0.09 |
0.02 |
0.01 |
0.02 |
0.00 |
| Retained earnings |
-2.69 |
-2.59 |
-2.49 |
-2.39 |
-2.29 |
-2.18 |
-2.05 |
-1.91 |
-1.77 |
-1.66 |
-1.53 |
-1.40 |
-1.28 |
-1.18 |
-1.06 |
-0.95 |
-0.85 |
-0.70 |
-0.62 |
-0.55 |
-0.48 |
-0.44 |
-0.39 |
-0.37 |
-0.33 |
-0.30 |
-0.27 |
-0.25 |
-0.22 |
-0.20 |
-0.18 |
-0.16 |
-0.14 |
-0.12 |
-0.10 |
-0.08 |
-0.07 |
-0.05 |
-0.04 |
-0.04 |
-0.03 |
-0.02 |
-0.02 |
-0.01 |
|
-0.01 |
|
| Common shares outstanding |
118 |
108 |
110 |
104 |
104 |
102 |
101 |
97 |
96 |
90 |
89 |
88 |
88 |
81 |
76 |
76 |
75 |
74 |
74 |
68 |
67 |
61 |
59 |
53 |
50 |
49 |
49 |
46 |
45 |
44 |
43 |
43 |
42 |
39 |
35 |
35 |
35 |
35 |
34 |
19 |
34 |
18 |
18 |
18 |
18 |
3 |
3 |
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
Dec-21 |
Dec-20 |
Dec-19 |
Dec-18 |
Dec-17 |
Dec-16 |
Dec-15 |
Dec-14 |
| Net income |
|
|
|
|
|
|
|
|
|
|
|
|
| Depreciation, depletion and amortization |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Stock-based compensation |
0.15 |
0.15 |
0.13 |
0.09 |
0.05 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.00 |
0.00 |
| Change in inventory |
|
|
-0.02 |
|
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
| Other working capital changes |
-0.51 |
-0.51 |
-0.52 |
-0.43 |
-0.29 |
-0.08 |
-0.13 |
-0.09 |
-0.08 |
0.03 |
0.00 |
0.00 |
| Capital expenditures |
-0.01 |
-0.01 |
-0.01 |
-0.06 |
-0.01 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
0.00 |
| Others incl. marketable securities changes |
0.13 |
0.13 |
-0.02 |
0.22 |
-0.54 |
-0.21 |
0.03 |
-0.25 |
0.00 |
0.00 |
0.00 |
0.00 |
| Dividend payout |
|
|
|
|
|
|
|
|
0.00 |
0.00 |
|
|
| Common stock repurchases |
|
|
|
0.58 |
1.86 |
0.37 |
0.08 |
0.04 |
0.14 |
0.00 |
0.00 |
0.00 |
| Net Debt Issuance |
0.19 |
0.19 |
0.13 |
0.00 |
-1.12 |
0.00 |
0.00 |
0.00 |
0.00 |
0.17 |
0.07 |
0.02 |
|
| Change in cash |
-0.04 |
-0.04 |
-0.30 |
0.41 |
-0.04 |
0.11 |
0.00 |
-0.28 |
0.07 |
0.20 |
0.07 |
0.01 |
Show Quarterly Cash Flow
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Dec-23 |
Sep-23 |
Jun-23 |
Mar-23 |
Dec-22 |
Sep-22 |
Jun-22 |
Mar-22 |
Dec-21 |
Sep-21 |
Jun-21 |
Mar-21 |
Dec-20 |
Sep-20 |
Jun-20 |
Mar-20 |
Dec-19 |
Sep-19 |
Jun-19 |
Mar-19 |
Dec-18 |
Sep-18 |
Jun-18 |
Mar-18 |
Dec-17 |
Sep-17 |
Jun-17 |
Mar-17 |
Dec-16 |
Sep-16 |
Jun-16 |
Mar-16 |
Dec-15 |
Sep-15 |
Jun-15 |
Mar-15 |
Dec-14 |
Jun-14 |
| Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Depreciation, depletion and amortization |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Stock-based compensation |
0.01 |
0.09 |
0.02 |
0.02 |
0.02 |
0.04 |
0.04 |
0.04 |
0.03 |
0.04 |
0.04 |
0.04 |
0.03 |
0.02 |
0.03 |
0.02 |
0.02 |
0.01 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Change in inventory |
|
|
|
|
|
|
|
|
|
-0.01 |
0.00 |
0.00 |
|
|
|
|
|
0.01 |
-0.01 |
0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
| Other working capital changes |
-0.13 |
-0.16 |
-0.10 |
-0.12 |
-0.17 |
-0.13 |
-0.13 |
-0.10 |
-0.16 |
-0.12 |
-0.14 |
-0.13 |
-0.14 |
-0.12 |
-0.11 |
-0.11 |
-0.10 |
-0.09 |
-0.08 |
-0.08 |
-0.05 |
-0.05 |
-0.04 |
0.05 |
-0.04 |
-0.04 |
-0.03 |
-0.04 |
-0.02 |
-0.01 |
-0.02 |
-0.03 |
-0.02 |
-0.03 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
-0.01 |
0.07 |
-0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Capital expenditures |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.05 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Others incl. marketable securities changes |
0.07 |
0.03 |
0.00 |
0.11 |
0.10 |
0.15 |
-0.01 |
-0.02 |
0.01 |
0.05 |
0.08 |
-0.03 |
-0.12 |
-0.03 |
0.05 |
0.10 |
0.09 |
-0.16 |
-0.39 |
0.04 |
-0.02 |
-0.21 |
-0.15 |
0.09 |
0.06 |
0.03 |
-0.03 |
0.02 |
0.01 |
-0.25 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Dividend payout |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
| Common stock repurchases |
|
|
|
|
|
|
|
|
|
|
|
|
0.00 |
0.51 |
0.02 |
0.01 |
0.05 |
1.13 |
0.67 |
0.01 |
0.06 |
0.23 |
0.00 |
0.13 |
0.00 |
0.02 |
0.05 |
0.01 |
0.00 |
0.03 |
0.00 |
0.00 |
0.01 |
0.14 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.17 |
0.00 |
0.00 |
0.00 |
|
0.00 |
0.00 |
|
| Net Debt Issuance |
0.03 |
0.00 |
0.11 |
0.01 |
0.00 |
0.00 |
0.08 |
0.04 |
0.06 |
0.11 |
0.02 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-1.12 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.07 |
0.00 |
0.00 |
0.01 |
0.00 |
|
| Change in cash |
-0.02 |
-0.04 |
0.04 |
0.02 |
-0.05 |
0.07 |
-0.01 |
-0.04 |
-0.05 |
0.06 |
0.00 |
-0.12 |
-0.23 |
0.39 |
-0.01 |
0.02 |
0.01 |
-0.21 |
0.20 |
-0.01 |
-0.02 |
-0.02 |
-0.18 |
0.28 |
0.02 |
0.02 |
-0.01 |
0.00 |
-0.01 |
-0.23 |
-0.01 |
-0.02 |
-0.01 |
0.12 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
0.24 |
-0.01 |
-0.01 |
0.06 |
0.00 |
0.01 |
0.01 |
0.00 |
Intellia Therapeutics, Inc. (NTLA) - Shares Outstanding Diluted
Intellia Therapeutics, Inc. (NTLA) - Dividend Payout
Intellia Therapeutics, Inc. (NTLA) - Change In Cash And Cash Equivalents
Intellia Therapeutics, Inc. (NTLA) - Proceeds From Repurchase Of Equity
Intellia Therapeutics, Inc. (NTLA) - Change In Inventory
Intellia Therapeutics, Inc. (NTLA) - Net Income
Intellia Therapeutics, Inc. (NTLA) - Stock Based Compensation
Intellia Therapeutics, Inc. (NTLA) - Cashflow From Financing
Intellia Therapeutics, Inc. (NTLA) - Cashflow From Investment
Intellia Therapeutics, Inc. (NTLA) - Capital Expenditures